A Search Service for Abbreviation / Long Form

â–  Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : qHPV
Long Form : quadrivalent HPV
No. Year Title Co-occurring Abbreviation
2020 Dose-related Effectiveness of Quadrivalent Human Papillomavirus Vaccine Against Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study. CIs, HPV, IRRs
2020 Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV. WLWH
2020 Post-approval Safety Monitoring of Quadrivalent and Bivalent Human Papillomavirus Vaccines Based on Real-world Data from the Korea Adverse Events Reporting System (KAERS). AEs, bHPV, KAERS
2019 Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine. 9vHPV, GMTs
2019 Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population. CI
2019 Safety and Immunogenicity of the Quadrivalent HPV Vaccine in Japanese Boys: a Phase 3, Open-Label Study. HPV
2018 A Review of the Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: 10 Years of Clinical Experience in Canada. AGW
2018 Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1. HPV
2018 Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs. HPV
10  2018 Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions. ---
11  2018 Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries. 9vHPV, AEs
12  2018 Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial). HPV, ISRCTN
13  2018 Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. HPV, RRs
14  2018 Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy. VE
15  2018 Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status. SAEs
16  2018 Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism. CIs, HPV, RRs
17  2018 Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26years of age. 9vHPV, AEs
18  2017 9-Valent human papillomavirus vaccine: a review of the clinical development program. 9vHPV
19  2017 Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine. HPV, LTFU
20  2017 Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM). HR-HPV, HSIL, MSM
21  2017 Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM). HR-HPV, HSIL, MSM
22  2017 The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus. Ab, AE, GMTs, nvAE, VSRs
23  2016 A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. ---
24  2016 HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine. ---
25  2016 Prophylactic HPV vaccination and anal cancer. MSM
26  2016 Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study. CIN, HPV, IRRs
27  2016 Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials. 9vHPV, AEs
28  2015 A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. HPV
29  2015 A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil in 9-15-Year-Old Girls. 9vHPV
30  2015 Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine. HPV
31  2015 Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. HPV
32  2015 Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy. LMIC
33  2014 Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. PsV NAb, TIgG
34  2014 Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers. bHPV, HPV, nHPV
35  2012 Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. HPV
36  2011 Gardasilâ„¢ HPV vaccination: surveillance of vaccine usage and adherence in a military population. IP, ITT